The J. M. Smucker Company (SJM) is upgraded to Buy, driven by operational improvements, portfolio rebalancing, and Elliott Management's activist involvement. SJM delivered Q3'FY26 revenue and EPS beats, with pricing actions offsetting volume declines and margin compression amid a tough consumer environment. Management targets >$1 billion FCF, significant debt reduction, and >10% total shareholder returns, supported by a 4.3% dividend yield and disciplined payout policy.
Volatility is again picking up, and it's a good idea to focus more on safety.
American Water Works is a real-life version of Monopoly's Water Works, returning steady and growing dividends to its shareholders for 17 years straight. AWK's $19 billion to $20 billion five-year capex plan (not including Essential Utilities) should power solid adjusted EPS growth. The water utility's debt-to-capital ratio remains below its long-term target, and it had almost $1.2 billion of liquidity to close out 2025.
The market is starting to flood back into defensive and Dividend Aristocrat stocks before the economic pendulum swings the other way.
Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from the prior quarterly rate.
Dividend aristocrats tend to be some of the most reliable stocks. These companies have raised dividends for at least 25 consecutive years, showing steady long-term growth and strong financial discipline.
Kimberly-Clark Corp. (NASDAQ: KMB) is undergoing the largest transformation in its 150-year history while maintaining a dividend that has increased for 54 consecutive years.
T. Rowe Price Group, Inc. is reiterated as a Strong Buy, supported by a pristine balance sheet, robust free cash flow, and a compelling >8% combined yield. TROW delivered record AUM of $1.78 trillion despite $56.9 billion net outflows in 2025, aided by strong market returns and product diversification. Strategic initiatives include ETF launches, global expansion, and a partnership with Goldman Sachs, signaling adaptability and a potential safety net.
J.M. Smucker is a value and income play, trading at a forward P/E of 11.6 and yielding 4.2%. SJM faces margin pressures, but portfolio simplification and cost savings are expected to stabilize profitability. Growth drivers like Uncrustables and Café Bustelo, combined with a well-covered dividend, support a "Buy" rating for potential strong total returns.
McCormick is a Dividend Aristocrat that trades above intrinsic value, with a Hold rating justified by premium valuation and macro pressures not properly reflected. MKC's dividend comes with an ~80% payout ratio, currently trading at one of their highest yields, but consumer weakness and tariffs weigh on performance. Despite strategic sourcing and productivity initiatives, MKC faces intensifying competition from private labels and relies heavily on global supply chains.
Kimberly-Clark offers compelling value, trading near 52-week lows, with a 5% dividend yield and a forward P/E of 13.5. The planned Kenvue merger, despite market skepticism, positions KMB as a global consumer health leader, with $32 billion in annual revenue and $1.9 billion in expected synergies. KMB maintains robust profitability, a 20.7% ROIC, an 'A' credit rating, and a well-covered dividend, with 53 consecutive years of growth.
Kraft Heinz (NASDAQ: KHC) and PepsiCo (NASDAQ: PEP) both beat Q3 2025 earnings, but the results highlight two packaged food giants on starkly different trajectories.